NYSEAMERICAN : PMI
Picard Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 7.874 USD (Oct 30, 2026, 10:00 AM EDT) · Market cap 18.41M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 19.53M |
| Enterprise Value | 21.07M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.34M |
| Shares Outstanding | 2.34M |
| Shares Change (YoY) | +802.75% |
| Shares Change (QoQ) | +24.66% |
| Owned by Insiders (%) | 4.52% |
| Owned by Institutions (%) | 10.37% |
| Float | 1.28M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.10 |
| Forward PS | 3.37 |
| PB Ratio | 10.00 |
| P/TBV Ratio | 30.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.02 |
| Quick Ratio | 0.09 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.24 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -93.62% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -910.84% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $84,000 |
| Profits Per Employee | -$352,227 |
| Employee Count | 75 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 0.79 |
Taxes
| Measure | Value |
|---|
| Income Tax | 11,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -94.91% |
| 50-Day Moving Average | 7.18 |
| 200-Day Moving Average | 30.43 |
| Relative Strength Index (RSI) | 50.20 |
| Average Volume (20 Days) | 560,480 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 51,356 |
| Short Previous Month | 231,853 |
| Short % of Shares Out | 2.20% |
| Short % of Float | 4.01% |
| Short Ratio (days to cover) | 0.13 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 6.30M |
| Gross Profit | 1.17M |
| Operating Income | -15.63M |
| Pretax Income | -27.98M |
| Net Income | -26.42M |
| EBITDA | -15.46M |
| EBIT | -15.63M |
| Loss Per Share | -$17.88 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 38,000 |
| Total Debt | 1.58M |
| Net Cash | -1.54M |
| Net Cash Per Share | -$0.66 |
| Equity (Book Value) | 1.72M |
| Book Value Per Share | 0.83 |
| Working Capital | 141,000 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -16.04M |
| Capital Expenditures | -26,000 |
| Depreciation & Amortization | 172,000 |
| Net Borrowing | -1.90M |
| Free Cash Flow | -16.07M |
| FCF Per Share | -$6.87 |
Margins
| Measure | Value |
|---|
| Gross Margin | 18.60% |
| Operating Margin | -248.10% |
| Pretax Margin | -444.16% |
| Profit Margin | n/a |
| EBITDA Margin | -245.37% |
| EBIT Margin | -248.10% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -802.75% |
| Shareholder Yield | -802.75% |
| Earnings Yield | -214.18% |
| FCF Yield | -82.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 3, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.44 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |